4-Aminopyridine
4-Aminopyridine is a pyridine derivative used as a potassium channel blocker in multiple sclerosis treatment (dalfampridine). It qualifies for HTS 2933.39.41.00 as a drug containing an unfused pyridine ring, meeting Chapter 29 criteria for nitrogen-heterocyclic compounds. Pharmaceutical grade material supports neurological therapeutic applications.
Import Duty Rates by Country of Origin
| Origin Country | MFN Rate | Ch.99 Surcharges | Total Effective Rate |
|---|---|---|---|
| π¨π³China | 6.5% | β | 6.5% |
| π²π½Mexico | 6.5% | β | 6.5% |
| π¨π¦Canada | 6.5% | β | 6.5% |
| π©πͺGermany | 6.5% | β | 6.5% |
| π―π΅Japan | 6.5% | β | 6.5% |
Alternative Classifications
This product could be classified differently depending on its characteristics or intended use.
If sold for non-pharmaceutical research use
Amino compounds without specified drug end-use may classify under general amino pyridine heading.
If not qualifying as 'drugs'
Non-drug pyridine compounds fall under the 'other' subcategory without drug specification.
If lab reagent mixture
Research-grade mixtures with solvents shift from pure compounds to diagnostic reagents.
Not sure which classification is right?
Our AI classifier can analyze your specific product and recommend the correct HTS code with confidence.
Import Tips & Compliance
β’ Provide FDA Investigational New Drug (IND) documentation and synthetic route confirming pyridine structure
β’ Include stability data showing no degradation to non-heterocyclic amines during transport
β’ Declare as bulk API only; formulated products go to Chapter 30
Related Products under HTS 2933.39.41.00
Nicotine Bitartrate Dihydrate
Nicotine bitartrate dihydrate is a heterocyclic compound containing a pyridine ring, used primarily as a drug in smoking cessation aids and nicotine replacement therapies. It falls under HTS 2933.39.41.00 as a drug featuring an unfused pyridine ring structure within Chapter 29's scope for chemically defined organic compounds. This classification applies to its pharmaceutical grade purity and medicinal application.
Pyridine-3-Carboxylic Acid (Niacin)
Niacin, or vitamin B3, is a pyridine derivative used as an essential drug for treating pellagra and managing dyslipidemia. Classified under HTS 2933.39.41.00 due to its unfused pyridine ring and status as a pharmaceutical drug within Chapter 29. Bulk USP-grade niacin powder qualifies as a chemically defined heterocyclic compound.
Pyridoxine Hydrochloride (Vitamin B6)
Pyridoxine HCl, a pyridine derivative, serves as the pharmaceutical form of vitamin B6 for treating deficiencies and nausea in pregnancy. Under HTS 2933.39.41.00 for its unfused pyridine ring and drug status per Chapter 29 scope. Bulk powder meets chemically defined compound requirements.
Isoniazid (Pyridine-4-Carboxylic Acid Hydrazide)
Isoniazid is a first-line antituberculosis drug featuring a pyridine carboxylic acid hydrazide structure. Classified in HTS 2933.39.41.00 as a drug with unfused pyridine ring under Chapter 29 heterocyclic provisions. Essential medicine status requires high purity bulk import form.
Ethionamide
Ethionamide, a thioamide derivative of pyridine-2-carboxylic acid, treats multidrug-resistant tuberculosis. Falls under HTS 2933.39.41.00 for its unfused pyridine ring and drug classification in Chapter 29. Bulk API form used in pharmaceutical manufacturing.
Metyrapone
Metyrapone, containing a methyl 1-(2-pyridyl)-1-propanone structure, inhibits cortisol synthesis in Cushing's syndrome treatment. HTS 2933.39.41.00 applies for its pyridine ring as a drug per Chapter 29 heterocyclic rules. Pharmaceutical bulk powder for API synthesis.